mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |